Connect the Dots

Event

In re Eyewear Antitrust Litigation: motion to dismiss granted (2025)

On 26 September 2025 a U.S. federal judge granted EssilorLuxottica’s motion to dismiss two proposed class actions by buyers, with leave to replead by 17 October 2025. The accusations were not tried.

3 links, 1 backed by primary records

Play the story Explore connections

Dates
26 Sep 2025

Connections 3

involved

  • EssilorLuxottica defendant; denied the accusations Primary record 12

    The court tested what the plaintiffs alleged, not proof. It found the markets they described not plausibly defined, and gave them until 17 October 2025 to file one last amended complaint. The later docket was not checked for this story. EssilorLuxottica entities face other class actions it disputes.

  • Ray-Ban brand of the defendant’s frames, as the report described the accusations Scholarship & press 2
  • Ray-Ban brand of the defendant’s frames, as the report described the suits Scholarship & press 2
Timeline 1 date
  1. 26 Sep 2025 In re Eyewear Antitrust Litigation: motion to dismiss granted (2025)
Proof 2 sources
  1. In re Eyewear Antitrust Litigation, 1:24-cv-4826 (S.D.N.Y.), Opinion and Order granting motion to dismiss, U.S. District Court, Southern District of New York, 26 Sep 2025. Primary record
    Defendants’ motion to dismiss is GRANTED. Plaintiffs’ Amended Complaints are dismissed with leave to replead.
    It is not illegal for a business to be enormous, and enormously successful, so long as it does not engage in anticompetitive conduct.
  2. EssilorLuxottica Defeats Consumer Lawsuits Alleging Monopoly Practices, Competition Policy International (reporting Reuters), 28 Sep 2025. Scholarship & press
    nothing more than a contention that building a successful company over many decades is unlawful.
    The cases had alleged that the maker of Ray-Ban and Oakley frames used acquisitions and restrictive agreements to inflate prices for prescription lenses and designer glasses,
Page history 1 change
  1. Add 55 stories, each checked against its sourcesAlibek96e92fe6

Something wrong or missing? Tell us, with a source, or edit this page.